Misplaced Pages

2-Benzylpiperidine

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by C6541 (talk | contribs) at 19:04, 4 April 2012 (References: clean up and typo fixing using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 19:04, 4 April 2012 by C6541 (talk | contribs) (References: clean up and typo fixing using AWB)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound
2-Benzylpiperidine
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers
IUPAC name
  • 2-benzylpiperidine
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
ECHA InfoCard100.046.581 Edit this at Wikidata
Chemical and physical data
FormulaC12H17N
Molar mass175.27 g/mol g·mol
3D model (JSmol)
SMILES
  • C1CCNC(C1)CC2=CC=CC=C2
InChI
  • InChI=1S/C12H17N/c1-2-6-11(7-3-1)10-12-8-4-5-9-13-12/h1-3,6-7,12-13H,4-5,8-10H2
  • Key:ITXCORRITGNIHP-UHFFFAOYSA-N
  (verify)

2-Benzylpiperidine is a stimulant drug of the piperidine class. It is similar in structure to other drugs such as methylphenidate and desoxypipradrol but around 20 times less potent, and while it boosts norepinephrine levels to around the same extent as d-amphetamine, it has very little effect on dopamine levels, with its binding affinity for the dopamine transporter around 175 times lower than for the noradrenaline transporter. 2-benzylpiperidine is little used as a stimulant, with its main use being as a synthetic intermediate in the manufacture of other drugs.

See also

References

  1. Ferris, RM; Tang, FL (1979). "Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-3Hnorepinephrine and 3Hdopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus". The Journal of pharmacology and experimental therapeutics. 210 (3): 422–8. PMID 39160.
  2. Kim, DI; Deutsch, HM; Ye, X; Schweri, MM (2007). "Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate". Journal of medicinal chemistry. 50 (11): 2718–31. doi:10.1021/jm061354p. PMID 17489581.
  3. Ablordeppey, SY; Fischer, JB; Law, H; Glennon, RA (2002). "Probing the proposed phenyl-A region of the sigma-1 receptor". Bioorganic & medicinal chemistry. 10 (8): 2759–65. doi:10.1016/S0968-0896(02)00096-2. PMID 12057665.
  4. Ágai B, Proszenyák A, Tárkányi G, Vida L, Faigl F. Convenient, Benign and Scalable Synthesis of 2- and 4-Substituted Benzylpiperidines. European Journal of Organic Chemistry 2004; 17:3623-3632. doi:10.1002/ejoc.200400215
  5. Christopher F. Bigge, John F. W. Keana, Sui Xiong Cai, Eckard Weber, Richard Woodward, Nancy C. Lan, Anthony P. Guzikowski. 2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists. US Patent 6124317
Stimulants
Adamantanes
Adenosine antagonists
Alkylamines
Ampakines
Arylcyclohexylamines
Benzazepines
Cathinones
Cholinergics
Convulsants
Eugeroics
Oxazolines
Phenethylamines
Phenylmorpholines
Piperazines
Piperidines
Pyrrolidines
Racetams
Tropanes
Tryptamines
Others
ATC code: N06B
Adrenergic receptor modulators
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
Dopamine receptor modulators
D1-like
Agonists
PAMs
Antagonists
D2-like
Agonists
Antagonists
Categories: